Microdosing, or low-dose treatment of psychedelics such as lysergic acid diethylamide (LSD), has gained popularity in recent years as a potential method for alleviating symptoms of attention-deficit/hyperactivity disorder (ADHD). However, the first-ever randomized clinical trial investigating the pharmacological effects of psychedelics found that microdosing LSD is as effective as a placebo in improving ADHD symptoms.
This article was originally published on MedicalXpress.com